SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-22-015713
Filing Date
2022-04-26
Accepted
2022-04-26 16:32:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A kzr-defa14a_20220426.htm DEFA14A 18453
2 GRAPHIC gfyxy4br0zit000002.jpg GRAPHIC 313757
3 GRAPHIC gfyxy4br0zit000001.jpg GRAPHIC 495282
  Complete submission text file 0001564590-22-015713.txt   1133347
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38542 | Film No.: 22854833
SIC: 2834 Pharmaceutical Preparations